Clinical trials recruiting for Metastatic Cancer
31
Recruiting trials
33
US states with sites
17
Countries
3%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 12 |
| Florida | 10 |
| New York | 10 |
| California | 8 |
| North Carolina | 8 |
| Ohio | 6 |
| Pennsylvania | 6 |
| Tennessee | 6 |
| Colorado | 5 |
| Massachusetts | 5 |
| Michigan | 5 |
| Oregon | 5 |
Top cities
Houston, Texas 10Los Angeles, California 6Nashville, Tennessee 6New York, New York 6Boston, Massachusetts 5Dallas, Texas 5Portland, Oregon 5San Antonio, Texas 5Austin, Texas 4Durham, North Carolina 4
Self-screener
Recruiting trials
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- A Study of MGC026 in Participants With Advanced Solid Tumors
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Biomarkers to Detect Endocrine Therapy Resistance
- COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
- Comprehensive Outcomes for After Cancer Health
- DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
- Definitive Radiation for High-Risk Spine Metastases
- Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Liver Embolization Approaches for Tumor Management
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Metastases Directed Therapy for Oligometastatic Breast Cancer
- Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
- OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
- Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- PRE-ISPY Phase I/II Oncology Platform Program
- PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
- PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer
- Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors
- Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
- Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Related conditions
Trials recruiting for Metastatic Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Lung cancer 2180Colorectal cancer 1359Prostate cancer 1234Melanoma 487Advanced Cancer 25Pancreatic cancer 870Non-small cell lung cancer 507Triple-negative breast cancer 138Ovarian cancer 118
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.